<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR35">
 <label>35.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Iyer</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Hall</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Das</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Mortell</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Ramirez</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>S</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism</article-title>
  <source>Clin Pharmacol Ther</source>
  <year>1999</year>
  <volume>65</volume>
  <fpage>576</fpage>
  <lpage>582</lpage>
  <pub-id pub-id-type="doi">10.1016/S0009-9236(99)70078-0</pub-id>
  <?supplied-pmid 10340924?>
  <pub-id pub-id-type="pmid">10340924</pub-id>
 </element-citation>
</ref>
